Thalgott, M., Rack, B., Eiber, M., Souvatzoglou, M., Heck, M. M., Kronester, C., . . . Nawroth, R. (2015). Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients. BMC Cancer.
Chicago ZitierstilThalgott, Mark, et al. "Categorical Versus Continuous Circulating Tumor Cell Enumeration As Early Surrogate Marker for Therapy Response and Prognosis During Docetaxel Therapy in Metastatic Prostate Cancer Patients." BMC Cancer 2015.
MLA ZitierstilThalgott, Mark, et al. "Categorical Versus Continuous Circulating Tumor Cell Enumeration As Early Surrogate Marker for Therapy Response and Prognosis During Docetaxel Therapy in Metastatic Prostate Cancer Patients." BMC Cancer 2015.